Takeda will stop manufacturing its medication Natpara for a rare endocrine condition at the end of 2024 after failing to resolve longstanding production issues.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,